<DOC>
	<DOC>NCT02242981</DOC>
	<brief_summary>This type of study is called a radiolabeled study. For this study, LY2623091 (study drug) has been specially prepared to contain radiolabeled carbon [^14C]. [^14C] is a naturally occurring radioactive form of the element, carbon. This study will increase understanding about how the drug appears in the blood, urine, and stool after it is administered to healthy participants. Information about any side effects that may occur will also be collected. This study will last up to 22 days for each participant, not including screening. Screening is required within 28 days prior to enrollment</brief_summary>
	<brief_title>A Study of How the Body Breaks Down and Eliminates LY2623091</brief_title>
	<detailed_description />
	<criteria>Overtly healthy males; as determined by physical examination, clinical laboratory tests, medical history and electrocardiograms (ECGs). With a body mass index of 18.5 to 32.0 kilogram per square meter (kg/m^2), inclusive.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>